The following represents disclosure information provided by authors of this abstract. ASCO's Quality Care Symposium Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Central reporting of human epidermal growth factor receptor-2 (HER2) status and adherence to testing and adjuvant trastuzumab treatment guidelines in Ontario.
Craig Earle
No relevant relationships to disclose
Ilia L. Ferrusi
No relevant relationships to disclose
Maureen E. Trudeau
No relevant relationships to disclose
Natasha B. Leighl
No relevant relationships to disclose
Eleanor Pullenayegum
No relevant relationships to disclose
Hoa Khong
No relevant relationships to disclose
Jeffrey Hoch
No relevant relationships to disclose
Deborah Marshall
No relevant relationships to disclose